Novo Nordisk stock surges 7% after Ozempic maker’s latest weight loss drug shows promise ...Middle East

Fortune - News
The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger. Read More

Read More Details
Finally We wish PressBee provided you with enough information of ( Novo Nordisk stock surges 7% after Ozempic maker’s latest weight loss drug shows promise )

Also on site :